Summit Therapeutics SMMT Operating lease right-of-use assets and lease liabilities, net
Operating lease right-of-use assets and lease liabilities, net at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept smmt:IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndOperatingLeaseLiabilityNet.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's operating lease right-of-use assets and lease liabilities, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's operating lease right-of-use assets and lease liabilities, net?
- Summit Therapeutics (SMMT) reported operating lease right-of-use assets and lease liabilities, net of $365K in Q1 2026.
- How has Summit Therapeutics's operating lease right-of-use assets and lease liabilities, net changed year-over-year?
- Summit Therapeutics's operating lease right-of-use assets and lease liabilities, net increased by 1360.0% year-over-year, from $25K to $365K.
- What does operating lease right-of-use assets and lease liabilities, net mean?
- The net cash flow impact resulting from the company's operating lease obligations.
- How do you interpret operating lease right-of-use assets and lease liabilities, net?
- Reflects the cash outflow associated with lease payments relative to the non-cash amortization of the lease asset.
- How does operating lease right-of-use assets and lease liabilities, net compare across companies?
- Standardized under ASC 842; comparable across all companies with significant office or facility lease footprints.